BRIEF RESEARCH REPORT article
Front. RNA Res.
Sec. RNP Biogenesis and Function
This article is part of the Research TopicCurrent Insights in RNA ResearchView all articles
A G-quadruplex structure in the SARS-CoV-2 RNA recruits Human Topoisomerase I
Provisionally accepted- 1University of Siegen, Siegen, Germany
- 2Luxembourg Institute of Health, Strassen, Luxembourg
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The COVID-19 pandemic has led to millions of deaths. Although the pandemic state has been declared to have ended and the disease has become endemic, the number of circulating SARS-CoV-2 variants and the lack of decreasing trends around the world highlight the challenge the virus still poses. The viral RNA genome contains several structural elements including G-quadruplexes. These structures may facilitate the binding between an RNA and RNA-binding proteins. Herein, we investigated host cell proteins that get trapped by a G-quadruplex structure of the SARS-CoV-2 RNA. The identified proteins include the human DNA topoisomerase 1 (TOP1). The protein is known to interact with G-quadruplex-DNA, but here, we show an interaction with a G-quadruplex structure formed by the RNA of SARS-CoV-2, which has not been reported before. TOP1 may be recruited by the non-canonical secondary structure to resolve it, which may enhance viral replication. Interestingly, previous studies showed that TOP1 inhibition can suppress SARS-CoV-2-induced inflammation. Thus, after discovery of TOP1 as a binding partner of the SARS-CoV-2 G-quadruplex structure, we tested different compounds for their effect on the recruitment of TOP1 to the G-quadruplex. Notably, our data suggest that the known alkaloid berberine can stabilize the TOP1-G4-RNA-complex. Functionally, TOP1 is possibly recruited by the G-quadruplex to resolve this secondary structure, thereby enhancing viral replication. Thus, berberine is a promising lead compound that may inhibit viral replication.
Keywords: COVID-19, G-quadruplex, RNA-Binding Protein, SARS-CoV-2, topoisomerase I
Received: 10 Oct 2025; Accepted: 08 Dec 2025.
Copyright: © 2025 Burghaus, Staschko, Mendes, Dittmar, Ihmels and Krauß. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sybille Krauß
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
